News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
551,535 Results
Type
Article (38694)
Company Profile (173)
Press Release (512668)
Multimedia
Podcasts (88)
Webinars (11)
Section
Business (165215)
Career Advice (2214)
Deals (28718)
Drug Delivery (115)
Drug Development (69017)
Employer Resources (142)
FDA (13329)
Job Trends (12608)
News (281299)
Policy (26157)
Tag
Academia (2147)
Accelerated approval (6)
Adcomms (23)
Allergies (83)
Alliances (39573)
ALS (91)
Alzheimer's disease (1252)
Antibody-drug conjugate (ADC) (136)
Approvals (13310)
Artificial intelligence (238)
Autoimmune disease (27)
Automation (11)
Bankruptcy (243)
Best Places to Work (9765)
BIOSECURE Act (16)
Biosimilars (108)
Biotechnology (92)
Bladder cancer (75)
Brain cancer (26)
Breast cancer (251)
Cancer (2020)
Cardiovascular disease (173)
Career advice (1855)
Career pathing (30)
CAR-T (123)
Cell therapy (335)
Cervical cancer (18)
Clinical research (56854)
Collaboration (732)
Company closure (2)
Compensation (506)
Complete response letters (24)
COVID-19 (2279)
CRISPR (41)
C-suite (225)
Cystic fibrosis (81)
Data (2024)
Decentralized trials (2)
Denatured (22)
Depression (45)
Diabetes (246)
Diagnostics (5351)
Digital health (14)
Diversity (7)
Diversity, equity & inclusion (31)
Drug discovery (109)
Drug pricing (126)
Drug shortages (31)
Duchenne muscular dystrophy (91)
Earnings (71453)
Editorial (45)
Employer branding (16)
Employer resources (126)
Events (81701)
Executive appointments (667)
FDA (14503)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (5)
Funding (612)
Gene editing (100)
Generative AI (24)
Gene therapy (282)
GLP-1 (750)
Government (3659)
Grass and pollen (5)
Guidances (165)
Healthcare (14738)
Huntington's disease (20)
IgA nephropathy (29)
Immunology and inflammation (137)
Indications (27)
Infectious disease (2411)
Inflammatory bowel disease (123)
Inflation Reduction Act (9)
Influenza (43)
Intellectual property (88)
Interviews (396)
IPO (13211)
IRA (48)
Job creations (3206)
Job search strategy (1567)
Kidney cancer (10)
Labor market (34)
Layoffs (434)
Leadership (23)
Legal (5845)
Liver cancer (62)
Lung cancer (299)
Lymphoma (144)
Machine learning (8)
Management (52)
Manufacturing (300)
MASH (72)
Medical device (9401)
Medtech (9406)
Mergers & acquisitions (16059)
Metabolic disorders (706)
Multiple sclerosis (72)
NASH (21)
Neurodegenerative disease (105)
Neuropsychiatric disorders (32)
Neuroscience (1786)
NextGen: Class of 2025 (5151)
Non-profit (3475)
Now hiring (26)
Obesity (398)
Opinion (251)
Ovarian cancer (60)
Pain (91)
Pancreatic cancer (77)
Parkinson's disease (146)
Partnered (18)
Patents (212)
Patient recruitment (98)
Peanut (44)
People (46402)
Pharmaceutical (80)
Pharmacy benefit managers (24)
Phase I (17747)
Phase II (24651)
Phase III (19291)
Pipeline (1348)
Policy (158)
Postmarket research (2099)
Preclinical (6662)
Press Release (52)
Prostate cancer (101)
Psychedelics (28)
Radiopharmaceuticals (221)
Rare diseases (349)
Real estate (4655)
Recruiting (57)
Regulatory (18555)
Reports (34)
Research institute (1930)
Resumes & cover letters (346)
Rett syndrome (1)
RNA editing (5)
RSV (47)
Schizophrenia (79)
Series A (111)
Series B (67)
Service/supplier (8)
Sickle cell disease (48)
Special edition (19)
Spinal muscular atrophy (149)
Sponsored (28)
Startups (3029)
State (2)
Stomach cancer (11)
Supply chain (63)
Tariffs (59)
The Weekly (64)
Vaccines (641)
Venture capitalists (40)
Weight loss (282)
Women's health (20)
Worklife (17)
Date
Today (221)
Last 7 days (845)
Last 30 days (2976)
Last 365 days (26926)
2025 (10371)
2024 (29037)
2023 (32768)
2022 (42450)
2021 (45459)
2020 (43805)
2019 (37784)
2018 (28877)
2017 (27390)
2016 (26462)
2015 (30314)
2014 (23654)
2013 (19699)
2012 (21161)
2011 (21764)
2010 (19566)
Location
Africa (748)
Alabama (43)
Alaska (5)
Arizona (141)
Arkansas (11)
Asia (34799)
Australia (5445)
California (5179)
Canada (1734)
China (464)
Colorado (218)
Connecticut (210)
Delaware (139)
Europe (76080)
Florida (827)
Georgia (150)
Idaho (34)
Illinois (462)
India (25)
Indiana (277)
Iowa (8)
Japan (170)
Kansas (97)
Kentucky (20)
Louisiana (11)
Maine (41)
Maryland (684)
Massachusetts (3820)
Michigan (162)
Minnesota (326)
Mississippi (1)
Missouri (60)
Montana (19)
Nebraska (20)
Nevada (48)
New Hampshire (59)
New Jersey (1568)
New Mexico (25)
New York (1390)
North Carolina (851)
North Dakota (5)
Northern California (2277)
Ohio (166)
Oklahoma (8)
Oregon (30)
Pennsylvania (1118)
Puerto Rico (13)
Rhode Island (25)
South America (1009)
South Carolina (10)
South Dakota (1)
Southern California (1999)
Tennessee (73)
Texas (768)
United States (19343)
Utah (140)
Virginia (138)
Washington D.C. (56)
Washington State (462)
West Virginia (2)
Wisconsin (57)
551,535 Results for "ea pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NewAmsterdam Pharma to Present New Clinical and Preclinical Data at 93rd EAS Congress
April 30, 2025
·
3 min read
Press Releases
NewAmsterdam Pharma Announces Late-Breaking Data from BROADWAY and TANDEM Pivotal Studies Published in Leading Medical Journals and Presented at the European Atherosclerosis Society (EAS) Congress 2025
May 7, 2025
·
12 min read
Pharm Country
Worldwide License Agreement for EA1080, Oral Selective α4β7 Integrin Antagonist, Signed between EA Pharma and Ensho Therapeutics
EA Pharma Co., Ltd. and Ensho Therapeutics, Inc. announced that the two companies have signed a worldwide exclusive license agreement for the rights to develop, manufacture and commercialize novel oral inflammatory bowel disease treatments EA1080 and a portfolio of other oral selective α4β7 integrin antagonists for the global market excluding Japan, China, Hong Kong, Macau, South Korea, Taiwan and ASEAN.
June 27, 2024
·
5 min read
Press Releases
Marea Therapeutics Announces Late-Breaking Oral Presentation at the 93rd EAS Congress
April 15, 2025
·
1 min read
Press Releases
Newron and EA Pharma (A Subsidiary of Eisai Co., Ltd.) Announce License Agreement for Evenamide in Japan and Other Asian Territories
December 13, 2024
·
11 min read
Press Releases
Scribe Therapeutics to Unveil Latest Preclinical Data on Proprietary CRISPR Epigenetic Silencing Technology for LDL-C Lowering at the 2025 EAS Congress
April 23, 2025
·
2 min read
Press Releases
Marea Therapeutics Presents Positive Data from Phase 2a Clinical Trial of MAR001, Being Developed for Cardiovascular Disease, in Late-Breaking Oral Session at the 93rd EAS Congress
May 7, 2025
·
5 min read
Tariffs
J&J CEO Duato Urges Tax Fix, Not Tariffs To Drive US Pharma Manufacturing
In the company’s first-quarter earnings call Tuesday, J&J CEO Joaquin Duato said there’s a better way to encourage drug manufacturing in the U.S. than President Donald Trump’s threatened pharma tariffs.
April 15, 2025
·
3 min read
·
Annalee Armstrong
Compensation
Top 6 Highest-Paid Pharma CEOs in 2024
Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
April 16, 2025
·
7 min read
·
Annalee Armstrong
Europe
With Tariffs Looming, EU and US Pharmas Make Demands of European Commission
Playing both sides of trade war, pharma companies are asking for certain compensations for scientific innovation and a smoother regulatory framework.
April 16, 2025
·
2 min read
·
Tristan Manalac
1 of 55,154
Next
